Fortress Biotech, Inc. (FBIO) is a publicly traded company in the Unknown sector. Across all available filings, 12 corporate insiders have executed 156 transactions totaling $11.4M, demonstrating a bullish sentiment with $9.7M in net insider flow. The most recent transaction on Jan 1, 2026 involved a transaction of 27,322 shares valued at $0.
No significant insider buying has been recorded for FBIO in the recent period.
No significant insider selling has been recorded for FBIO in the recent period.
Based on recent SEC filings, insider sentiment for FBIO is bullish with an Insider Alignment Score of 93/100 and a net flow of $9.7M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Fortress Biotech, Inc. (FBIO) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 12 insiders are actively trading FBIO stock, having executed 156 transactions in the past 90 days. The most active insider is Lindsay A. Rosenwald Md (Executive), who has made 41 transactions totaling $9.2M.
Get notified when executives and directors at FBIO file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 1, 2026 | Harvey Jimmie | Executive | Award | 27,322 | $N/A | $0 | |
| Jan 1, 2026 | Klein Dov | Executive | Award | 27,322 | $N/A | $0 | |
| Oct 1, 2025 | Jin David | Executive | Award | 2,711 | $1.31 | $3.6K | |
| Sep 23, 2024 | A. Rosenwald Lindsay Md | Executive | Purchase | 763,359 | $1.84 | $1.4M | Large |
| Jul 11, 2024 | A. Rosenwald Lindsay Md | Executive | Purchase | 5,000 | $7.48 | $37.4K | |
| Jul 10, 2024 | Jin David | Executive | Purchase | 500 | $7.50 | $3.8K | |
| Jul 9, 2024 | A. Rosenwald Lindsay Md | Executive | Purchase | 5,000 | $7.39 | $37.0K | |
| Jul 8, 2024 | A. Rosenwald Lindsay Md | Executive | Purchase | 5,000 | $7.35 | $36.8K | |
| May 20, 2024 | Klein Dov | Executive | Sale | 10,000 | $1.89 | $18.9K | |
| May 16, 2024 | A. Rosenwald Lindsay Md | Executive | Purchase | 10,000 | $1.76 | $17.6K | |
| Apr 1, 2024 | Jin David | Executive | Award | 2,352 | $1.70 | $4.0K | |
| Jan 5, 2024 | A. Rosenwald Lindsay Md | Executive | Purchase | 50,000 | $2.38 | $119.0K | |
| Jan 1, 2024 | A. Rosenwald Lindsay Md | Executive | Award | 216,465 | $N/A | $0 | |
| Jan 1, 2024 | K. Rowinsky Eric | Executive | Award | 6,666 | $N/A | $0 | |
| Jan 1, 2024 | S. Weiss Michael | Executive | Award | 216,465 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 34 | $10.5M | 85.8% |
Sale(S) | 16 | $826.8K | 6.7% |
Award(A) | 85 | $522.3K | 4.3% |
Disposition(D) | 14 | $397.7K | 3.2% |
Other(J) | 7 | $0 | 0.0% |
Insiders at Fortress Biotech, Inc. are accumulating shares at an accelerated pace. With 12 insiders making 156 transactions totaling $10.5M in purchases versus $826.8K in sales, the net buying activity of $9.7M signals strong executive confidence. Lindsay A. Rosenwald Md (Executive) leads the buying activity with $9.2M in transactions across all time.